Company Profile
Kossel Medtech (Suzhou) Co., Ltd was founded in 2013, specializing in coronary,peripheral intervention medical devices, electrophysiology series products and other related accessories. We also welcome OEM/ODM cooperation.
Our initial team members are experienced field experts from China and The USA. Our current core teams have more than 10 years of experience in the field and our total staff number exceeds 200 people.
With consistent innovation abilities, advanced production capacity and 10,000 square meters of professional facilities and laboratories; we have obtained more than 100 intellectual property rights or patents, passed ISO 9001, ISO 13485 and GMP systems. We were awarded CE, FDA, KFDA and PMDA certificates, and earned the honorary titles of a "Unicorn" and "Gazelle" company. We have also undertaken the commercialization projects of scientific and technological achievements from our government. Our products are used in dozens of countries and we have customers on every continent.
We devote ourselves to developing excellent products, strive to be an international leading enterprise in the intervention field and are fully committed to contributing to human well-being!
Our Mission: Develop superb medical devices for people's health and benefits.
Our Vision: Innovation for systematic clinical solutions, and a world-wide intervention leader.
Our Values: Be Pragmatic, Efficient, Collaborative, Willing to share, Hardworking and Dedication.
Product Features
L605 Co-Cr Alloy
1. The Spatial structure and open unit design increases flexibility, allows for reaching the stenosis quickly and merging with the vessel well
2. The thickness is 0.0032 inches, providing excellent tracking performance
3. The Ω structure has a large profile, offering strong support and good drug release
4. The "S" connection structure reduces the transverse shortening rate and allows for exceptional flexibility and conformability
Technical Specifications:
L605 Cobalt-Chromium Alloy
Profile 0.88-1.1mm
Redial recoil <3%
Axial foreshortening<5%
Strut thickness 0.0025"
Metal coverage rate 12.6 %( 3.0mm series)
Use Cobalt-chromium alloy as the stent material, thinner wall-thickness but stronger supporting force.
Use Biodegradable PLGA as drug carrier & release controller
The Sirolimus dosage is 8.5±2.1ug/mm
Size Matrix
| L/mm D/mm |
8 |
12 |
13 |
15 |
16 |
18 |
20 |
21 |
23 |
24 |
28 |
29 |
33 |
38 |
40 |
| 2.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
- |
- |
- |
- |
- |
| 2.25 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
- |
- |
- |
- |
- |
| 2.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 2.75 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 3.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 3.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 4.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 4.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
| 5.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Production Line
FAQ
){kind=link}